KR910021406A - 축합 티아졸 화합물, 그의 제조 방법 및 용도 - Google Patents

축합 티아졸 화합물, 그의 제조 방법 및 용도 Download PDF

Info

Publication number
KR910021406A
KR910021406A KR1019910002976A KR910002976A KR910021406A KR 910021406 A KR910021406 A KR 910021406A KR 1019910002976 A KR1019910002976 A KR 1019910002976A KR 910002976 A KR910002976 A KR 910002976A KR 910021406 A KR910021406 A KR 910021406A
Authority
KR
South Korea
Prior art keywords
compound
hydrogen atom
salt
optionally substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019910002976A
Other languages
English (en)
Korean (ko)
Inventor
데쓰야 아오노
마사히로 스노
고 기또
Original Assignee
우메모또 요시마사
다께다야꾸힝고오교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우메모또 요시마사, 다께다야꾸힝고오교 가부시끼가이샤 filed Critical 우메모또 요시마사
Publication of KR910021406A publication Critical patent/KR910021406A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019910002976A 1990-02-23 1991-02-23 축합 티아졸 화합물, 그의 제조 방법 및 용도 Ceased KR910021406A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP044095/1990 1990-02-23
JP4409590 1990-02-23
JP25965690 1990-09-27
JP259656/1990 1990-09-27

Publications (1)

Publication Number Publication Date
KR910021406A true KR910021406A (ko) 1991-12-20

Family

ID=26383943

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910002976A Ceased KR910021406A (ko) 1990-02-23 1991-02-23 축합 티아졸 화합물, 그의 제조 방법 및 용도

Country Status (11)

Country Link
US (1) US5153201A (enExample)
EP (1) EP0443588B1 (enExample)
KR (1) KR910021406A (enExample)
AT (1) ATE181553T1 (enExample)
AU (1) AU640449B2 (enExample)
CA (1) CA2036905C (enExample)
DE (1) DE69131359T2 (enExample)
IE (1) IE910570A1 (enExample)
IL (1) IL97249A (enExample)
NZ (1) NZ237187A (enExample)
TW (1) TW206970B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
US5653903A (en) * 1995-06-27 1997-08-05 Ppg Industries, Inc. L-shaped heating element with radiused end for a windshield
US5886321A (en) * 1996-12-19 1999-03-23 Ppg Industries, Inc. Arrangement for heating the wiper rest area of a vehicle windshield
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
US7361766B2 (en) 2005-01-12 2008-04-22 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
CN103002742B (zh) 2010-03-05 2016-07-13 卡尔约药物治疗公司 核转运调节剂及其应用
JP6106605B2 (ja) 2011-01-17 2017-04-05 カリオファーム セラピューティクス，インコーポレイテッド オレフィン含有核輸送調節剤およびその使用
CA2842364A1 (en) * 2011-07-29 2013-02-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
ES2954991T3 (es) 2011-07-29 2023-11-28 Karyopharm Therapeutics Inc Moduladores del transporte nuclear que contienen hidrazida y usos de los mismos
SMT202000347T1 (it) 2012-05-09 2020-07-08 Biogen Ma Inc Modulatori di trasporto nucleare e loro usi
WO2014144772A1 (en) 2013-03-15 2014-09-18 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
PL3010892T3 (pl) 2013-06-21 2019-07-31 Karyopharm Therapeutics, Inc. 1,2,4-triazole jako modulatory transportu jądrowego i ich zastosowania
CN111484483B (zh) 2014-08-15 2023-05-26 卡尔约药物治疗公司 赛灵克斯的多晶型物
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP3397633A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy
CN109134510A (zh) * 2018-11-13 2019-01-04 井冈山大学 制备2-氨基-5-cbz-4,5,6,7-四氢噻唑并[5，4-c]吡啶的新方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4924916B1 (enExample) * 1970-08-14 1974-06-26
IT1211027B (it) * 1981-04-24 1989-09-29 Crc Ricerca Chim Pina procedimento per la preparazione di _ una pirido-[2,3-b][1,4]benzodiaze
DE3545097A1 (de) * 1985-12-19 1987-07-02 Bayer Ag 1-h-pyrido-(3,2-b)(1,4)-thiazine
DE3701737A1 (de) * 1987-01-22 1988-08-04 Bayer Ag 1h-pyrido-(2,3-b)(1,4)-thiazine zur therapeutischen behandlung
DK196688A (da) * 1987-04-28 1988-10-29 Fujisawa Pharmaceutical Co Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
FI91859C (fi) * 1987-06-17 1994-08-25 Eisai Co Ltd Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
RU2073673C1 (ru) * 1987-10-19 1997-02-20 Пфайзер Инк. Рацемические и оптические активные производные тетралина и 7-гидрокситетралина
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP3054738B2 (ja) * 1988-07-22 2000-06-19 武田薬品工業株式会社 チアゾロ［５，４―ｂ］アゼピン誘導体

Also Published As

Publication number Publication date
IL97249A (en) 1995-01-24
DE69131359D1 (de) 1999-07-29
NZ237187A (en) 1992-10-28
AU7124391A (en) 1991-08-29
EP0443588B1 (en) 1999-06-23
IE910570A1 (en) 1991-08-28
ATE181553T1 (de) 1999-07-15
DE69131359T2 (de) 1999-10-14
CA2036905C (en) 2003-05-06
EP0443588A1 (en) 1991-08-28
IL97249A0 (en) 1992-05-25
US5153201A (en) 1992-10-06
AU640449B2 (en) 1993-08-26
TW206970B (enExample) 1993-06-01
CA2036905A1 (en) 1991-08-24

Similar Documents

Publication Publication Date Title
KR910021406A (ko) 축합 티아졸 화합물, 그의 제조 방법 및 용도
KR830009118A (ko) 세펨화합물의 제조방법
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
NO942309D0 (no) 5-amino-8-methyl-7-pyrrolidinylkinolin-3-carboxylsyrederivater
KR930016402A (ko) 항-hiv 활성을 갖는 이미다졸 유도체
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
KR910000751A (ko) 세펨 화합물 및 이의 제조방법
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
GB1062714A (en) -ß-(4'-acyloxy-4'-piperidyl)-ketones
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
KR920002517A (ko) 칼모둘린 억제 특성을 갖는 벤즈히드릴 유도체 및 그의 제조방법
FI875251A0 (fi) Foerfarande foer framstaellning av 2-arylpropionsyror.
JPS57188566A (en) 2-(3-(3-indolyl)-2-amino-propionyloxy)acetic acid derivative, manufacture and medicine containing same
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
NO180475C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat
IL59358A (en) Hydroxytetrahydro(phenoxymethyl)-imidazothiazole and thiazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ZA826183B (en) Derivatives of propan-2-ols,process for preparing these compounds,and pharmaceutical compositions thereof
DE69118129D1 (de) 1,2,3,6-Tetrahydronpyridinderivate
GB1120478A (en) Improvements in or relating to steroids and the manufacture thereof
KR890009941A (ko) 경구 투여 세팔로스포린 유도체와 이의 제조방법 및 이의 용도

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000